ErbB2/Her2 anticorps (pTyr1248)
-
- Antigène Voir toutes ErbB2/Her2 Anticorps
- ErbB2/Her2 (Receptor tyrosine-protein kinase erbB-2 (ErbB2/Her2))
-
Épitope
- pTyr1248
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ErbB2/Her2 est non-conjugé
-
Application
- Western Blotting (WB), Dot Blot (DB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Fonction
- Rabbit polyclonal antibody raised against synthetic phosphopeptide of ERBB2.
- Réactivité croisée
- Humain
- Attributs du produit
- Antibody Reactive Against Synthetic Peptide.
- Immunogène
- Synthetic phosphopeptide (conjugated with KLH) corresponding to residues surrounding Y1248 of human ERBB2.
- Top Product
- Discover our top product ErbB2/Her2 Anticorps primaire
-
-
- Indications d'application
-
Western Blot (1:8000)
Immunohistochemistry (1:50-1:100)
The optimal working dilution should be determined by the end user. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- In PBS (0.09 % sodium azide)
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
-
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
Identification and validation of novel ERBB2 (HER2, NEU) targets including genes involved in angiogenesis." dans: International journal of cancer. Journal international du cancer, Vol. 114, Issue 4, pp. 590-7, (2005) (PubMed).
: "Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice." dans: International journal of cancer. Journal international du cancer, Vol. 115, Issue 1, pp. 36-45, (2005) (PubMed).
: "Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone." dans: The Journal of nutrition, Vol. 135, Issue 5, pp. 983-8, (2005) (PubMed).
: "
-
Identification and validation of novel ERBB2 (HER2, NEU) targets including genes involved in angiogenesis." dans: International journal of cancer. Journal international du cancer, Vol. 114, Issue 4, pp. 590-7, (2005) (PubMed).
-
- Antigène
- ErbB2/Her2 (Receptor tyrosine-protein kinase erbB-2 (ErbB2/Her2))
- Autre désignation
- CD340 / ERBB2 / HER2 (ErbB2/Her2 Produits)
- Synonymes
- anticorps CD340, anticorps HER-2, anticorps HER-2/neu, anticorps HER2, anticorps MLN 19, anticorps NEU, anticorps NGL, anticorps TKR1, anticorps Erbb-2, anticorps Neu, anticorps c-erbB2, anticorps c-neu, anticorps mKIAA3023, anticorps wu:fv70f10, anticorps zgc:63601, anticorps erb2, anticorps erb-b2 receptor tyrosine kinase 2, anticorps ERBB2, anticorps Erbb2, anticorps erbb2
- ID gène
- 2064
- Pathways
- Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Skeletal Muscle Fiber Development
-